These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16244678)

  • 1. [Phencyclidine--angel dust].
    Høiseth G; Hjelmeland K; Bachs L
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2775-6. PubMed ID: 16244678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCP: from pharmacology to modelling schizophrenia.
    Morris BJ; Cochran SM; Pratt JA
    Curr Opin Pharmacol; 2005 Feb; 5(1):101-6. PubMed ID: 15661633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine, ketamine, and khat phencyclidine (PCP, DOA, 'angel dust', 'crystal', 'hog').
    O'Shea B
    Ir Med J; 2000 Sep; 93(6):185. PubMed ID: 11105446
    [No Abstract]   [Full Text] [Related]  

  • 4. DARK Classics in Chemical Neuroscience: Phencyclidine (PCP).
    Bertron JL; Seto M; Lindsley CW
    ACS Chem Neurosci; 2018 Oct; 9(10):2459-2474. PubMed ID: 29953199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
    Seillier A; Giuffrida A
    Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angel dust: medical and psychiatric aspects of phencyclidine intoxication.
    Robinson B; Yates A
    Ariz Med; 1984 Dec; 41(12):808-11. PubMed ID: 6517724
    [No Abstract]   [Full Text] [Related]  

  • 8. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
    Bäckberg M; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phencyclidine on spatial learning and memory: nitric oxide-dependent mechanisms.
    Wass C; Archer T; Pålsson E; Fejgin K; Klamer D; Engel JA; Svensson L
    Behav Brain Res; 2006 Jul; 171(1):147-53. PubMed ID: 16677724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the phencyclidine model of schizophrenia.
    Javitt DC; Zukin SR
    Am J Psychiatry; 1991 Oct; 148(10):1301-8. PubMed ID: 1654746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of phencyclidine (PCP)-n-methyl-d-aspartate (NMDA) receptor interaction: implications for drug abuse research.
    Zukin SR; Javitt DC
    NIDA Res Monogr; 1989; 95():247-54. PubMed ID: 2561829
    [No Abstract]   [Full Text] [Related]  

  • 12. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine Intoxication Case Series Study.
    Dominici P; Kopec K; Manur R; Khalid A; Damiron K; Rowden A
    J Med Toxicol; 2015 Sep; 11(3):321-5. PubMed ID: 25502414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of PCP, NMDA and opiate receptors.
    Wilkins J
    NIDA Res Monogr; 1989; 95():275-81. PubMed ID: 2577034
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Unusual Drug Screening Results.
    Chang BN; Smith MP
    Clin Chem; 2017 May; 63(5):958-961. PubMed ID: 28455300
    [No Abstract]   [Full Text] [Related]  

  • 17. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.
    Enomoto T; Noda Y; Nabeshima T
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
    Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells.
    Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF
    Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.